Investigation of the antioxidant status in multiple myeloma patients: Effects of therapy

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 6, 2013, Pages 3663-3667

  Mehdi, Wesen A ^a   Zainulabdeen, Jwan A ^a   Mehde, Atheer A ^b  

^a UNIVERSITY OF BAGHDAD   (Iraq)

^b MIDDLE TECHNICAL UNIVERSITY   (Iraq)

Author keywords

Antioxidant enzymes; Antioxidants; Multiple myeloma; Oxidation byproducts; Total antioxidant capacity

Indexed keywords

EID: 84882597831     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.6.3663     Document Type: Article

References (33)

1. Alexander DD, Mink PJ, Adami HO, et al (2007). Multiple myeloma: a review of the epidemiologic literature. Int J Cancer, 120, 40-61.
2. Beutler E, Duron O, Kelly BM (1963). Improved method for the determination of blood GSH. J Lab Clin Med, 61, 882-8.
3. Campanella A, Santambrogio P, Fontana F, et al (2012). Iron increases the susceptibility of multiple myeloma cells to bortezomib. Haematologica J, 10, 3324.
4. Chatterjea MN, Shinde R (2007). Textbook of medical biochemistry. 7th edn. Jaypee brothers medical publications, New Delhi. pp. 92-113.
5. Dierickx PJ (1999). Glutathione-dependent cytotoxicity of the chloroacetanilide herbicides alachlor, metolachlor, and propachlor in rat and human hepatoma-derived cultured cells. Cell Biol Toxicol, 15, 325-2.
6. Estakhri R, Hajipour B, Majidi H, Soleimani H (2013). Vitamin E ameliorates cyclophosphamide induced nephrotoxicity. Life Sci J, 10, 308-13.
7. Giusti G (1974). Adenosine deaminase. In: Bergneyer HU, Methods of enzymatic analysis. 2nd Edn., Academic Press Inc., New York, pp. 1092-8.
8. Hideshima T, Anderson KC (2002). Molecular mechanisms of novel therapeutic approaches for multiple myeloma. Nat Rev Cancer, 2, 927-37.
9. Ishikawa K, Takenaga K, Akimoto M, et al (2008). ROSgenerating mitochondrial DNA mutations can regulate tumor cell metastasis. Science, 320, 661-4.
10. Kaya E, Keskin L, Aydogdu I, et al (2005). Oxidant/antioxidant parameters and their relationship with chemotherapy in hodgkin's lymphoma. J Int Med Res, 33, 687-92.
11. Krzystek-Korpacka M, Patryn E, Boehm D, et al (2008). Advanced oxidation protein products (AOPPs) in juvenile overweight and obesity prior to and following weight reduction. Clinical Biochemistry, 41, 943-9.
12. Kyle RA, Rajkumar SV (2004). Multiple myeloma. N Engl J Med, 351, 1860-73.
13. Kyle RA, Rajkumar SV (2004) Plasma, cell disorders. In: Goldman L, Ausiello D, editors. Cecil textbook of medicine. Chapter 196. 2nd edn. Philadelphia, W.B. Saunders, pp. 1184-6.
14. Kyle RA, Rajkumar SV (2008). Multiple myeloma. Blood, 15, 2962-72.
15. Kyle RA, Rajkumar SV (2009). Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma. Leukemia, 23, 3-9.
16. Lee K, Koon IT, Mee AS (1975). A new colorimetric method for the determination of NADH/NADPH dependent GSSGRed in erythrocyte and in plasma. Clinica Chimica Acta, 58, 101-8.
17. Lenhinger AL (2005). Principles of biochemistry" 4th edn., H. Freeman and Company. New York, pp. 94.
18. Marnett LJ, Riggins JN, West JD (2003). Endogenous generation of reactive oxidants and electrophiles and their reactions with DNA and protein. J Clin Invest, 111, 583-93.
19. Márquez A, Villa-Trevino S, Gueraud F (2007). The LEC rat: a useful model for studying liver carcinogenesis related to oxidative stress and inflammation. Redox Rep, 12, 35-9.
20. Mehde A, Mehdi W, Jasim A (2013). Study several biochemical parameters into patient's with hepatitis B virus global. J Med Res Diseases, 13, 210.
21. Camilla R, Suzuki H, Dapra V, et al (2011). Oxidative stress and galactose-deficient IgA1 as markers of progression in IgA nephropathyst. Clin J Am Soc Nephrol, 6, 1903-11.
22. Misra HP, Fridovich I (1972). The role of superoxide anion in the auto oxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem, 247, 3170-5.
23. Munshi N (1997). Immunoregulatory mechanisms in multiple myeloma. Hematol Oncol Clin North Am, 11, 51-69.
24. O'Connell TX, Horita TJ, Kasravi B (2005). Understanding and Interpreting serum protein electrophoresis. Am Fam Physician, 71, 105-12.
25. Ottaviano FG, Handy, DE, Loscalzo J (2008). Redox regulation in the extracellular environment. Circ J, 72, 1-16.
26. Pleban PA, Munyani A, Beachum J (1982). Determination of selenium concentration and glutathione peroxidase activity in plasma and erythrocytes. Clin Chem, 28, 311-6.
27. Raab MS, Podar K, Breitkreutz I, et al (2009). Multiple myeloma. Lancet, 374, 324-39.
28. Ravaud P, Thepot C, Auleley GR, Amor B (1996). Imaging of multiple myeloma. Ann Med Interne, 147, 370-5.
29. Rice-Evans C, Mille NJ (1994). Total antioxidant status in sera and body fluids. In: Methods in Enzymology. New York: Academic Press, pp. 279-93.
30. Satoh K (1978). Plasma lipid peroxide in cerebrovascular disorders determined by new colorimetric method. Clin Chim Acta, 90, 37-43.
31. Sharma A, Tripathi M, Satyam A, Kumar L (2009). Study of antioxidant levels in patients with multiple myeloma. Leuk Lymphoma, 50, 809-15.
32. Waris G, Ahsan H (2006). Reactive oxygen species: role in the development of cancer and various chronic conditions. J Carcinogenesis, 14, 14-21.
33. Xuan-li Xu, Yi-hong S, Shen Q, Jian-ying Z (2013). Case of bilateral pleural effusion as the first sign of multiple myeloma. Eur J Med Res, 18, 7.